Health Care


FDA Takes Regulatory Action against Ranbaxy India Plant

The Food and Drug Administration recently announced that a facility owned by India-based Ranbaxy Laboratories falsified data and test results in approved and pending drug applications. The facility, Paonta Sahib, has been under an FDA Import Alert since September 2008.

Illinois Occupational Safety and Health Day Aims to Protect Employees

Making and keeping the workplace safe and healthful will be the focus of the 18th Annual Downstate Illinois Occupational Safety and Health (DIOSH) Day slated for March 4 at the Peoria Civic Center in Peoria, Ill. Workplace safety and health issues will be discussed and information made available to employers, employees and the general public.

CDC Launches RSS Feeds for Emergency Sites

The Centers for Disease Control and Prevention has just launched RSS feeds for two of the most popular sections of its emergency.CDC.gov Web site.

Safe Handling Awareness Month to Focus on Exposure to Hazardous Drugs

A free, one-hour safe handling CE webinar on the subject is planned for April 20--the inaugural Safe Handling Awareness Day--and all health care professionals are invited to participate.

CDC Report Points to Obesity, Injuries Among Young Adults

A special section in "Health, United States: 2008" examines the latest data available for U.S. residents ages 18-29 and identifies problem areas.

Cardinal Health 303 Inc Agrees to Correct GMP Violations

The Food and Drug Administration announced recently that California device manufacturer Cardinal Health 303 Inc., formerly known as Alaris Medical Systems Inc., and three of its top executives have signed an amended consent decree to correct violations of current Good Manufacturing Practice requirements in the company's infusion pumps.

Cardinal Health Spinoff Focused Solely on Patient Safety

The new company, CareFusion®, will be the largest medical technology company with patient safety as its sole focus, Cardinal Health said.



FDA Alerts Public of Serious Adverse Event with Psoriasis Drug Raptiva

The Food and Drug Administration has issued a public health advisory concerning three confirmed, and one possible report of progressive multifocal leukoencephalopathy (PML), a rare brain infection, in patients using the psoriasis drug Raptiva (efalizumab). Three of those patients have died. All four patients were treated with the drug for more than three years. None of the patients were receiving other treatments that suppress the immune system.

The White House will receive a special issue of NYCOSHs newsletter.

NYCOSH to Obama: Here's How to Fix OSHA

"OSHA should promulgate a number of exposure standards including silica, beryllium, diacetyl and combustible dust. But we need to acknowledge that the standard-setting process has become excruciatingly slow and cumbersome," writes Stuart Appelbaum, president of the Retail, Wholesale and Department Store Union, one of many contributors to a special newsletter produced for the new administration.

Free Hospital Emergency Readiness Webinar Offered

The roundtable at 2 p.m. Eastern next Tuesday features health care expercts on safety, security, and emergency preparedness from hospitals in California, New York, and Louisiana.

Traffic Air Pollution Linked to Repeated Hospital Encounters for Asthma

Air pollution caused by traffic near the home affects asthma severity in children, resulting in repeated hospital encounters, according to a study published this month in Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma, and Immunology.

American Dental Association Lauds 'Meth Mouth' Bill

Dr. John S. Findley, president of the American Dental Association (ADA), applauded Capitol Hill legislators for introducing a federal bill aimed at understanding and treating "meth mouth"--a condition where teeth can become blackened, stained, rotting, and crumbling from methamphetamine use.

White Patients Have Better Surgical Survival in Teaching Hospitals

Elderly patients who undergo surgery at teaching-intensive hospitals have better survival rates than at non-teaching hospitals, but these better survival rates apparently occur in white patients, not black patients, according to a new study that appears in the February issue of the Archives of Surgery.

Tips for Continuing Health Care during a Recession

During these tough economic times, the Institute for Good Medicine and the physician members of the Pennsylvania Medical Society are urging the public to protect their greatest asset--their health.

EPA to Review Bush Rules on Emissions

The EPA said it would reopen the possibility of regulating carbon dioxide emissions from coal-fired power plants, according to the Washington Post.

Survey: Gen-X Mostly Unprepared for Long-Term Care Costs

Half of respondents estimated the average annual nursing home stay is between $20,000 and 60,000 per year, when the national average cost of one year in a nursing home is more than $75,000.

New Studies Show Rates, Risk Factors of Patient Awareness during Anesthesia

How many patients experience unwanted awareness during general anesthesia for surgery? The true rate is low but difficult to determine, while certain factors seem to increase the risk, according to a pair of studies in the February issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

a red heart symbolizing the cost of a heart attack or critical illness

AHA Highlights Critical Illness Insurance

Noting February is American Heart Month and tomorrow turns people's attention to matters of the heart, the American Heart Association reminds us heart attack survivors may be financially strapped during recovery.

FDA, International SAE Consortium Release Genetic Data on Adverse Drug Events

The first data offering health care professionals a better look into the genetic basis of certain types of adverse drug events was released recently by the Food and Drug Administration and the International Serious Adverse Event Consortium (SAEC). The data are focused on the genetics associated with drug-induced serious skin rashes, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, and helps better predict an individual's risk of developing these reactions.

Featured

Artificial Intelligence

Webinars